Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02003924
Title Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Acronym PROSPER
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | SWE | SVK | POL | NZL | NLD | ITA | GRC | GBR | FRA | FIN | ESP | DNK | DEU | CAN | BRA | BEL | AUT | AUS | ARG


No variant requirements are available.